文献速递母胎医学产科

胎儿镜下气管封堵术治疗先天性膈疝:系统综述与Meta分析

Fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia: systematic review and meta-analysis.
PubMed 文献 · Ultrasound Obstet Gynecol · 2023-05-11

该系统综述与Meta分析纳入20项研究共1187例先天性膈疝胎儿,评估胎儿镜下气管封堵术(FETO)的疗效。FETO显著降低1个月和6个月死亡率,在重度膈疝中显著降低肺动脉高压率和ECMO使用率,但增加37周前胎膜早破和早产风险。

要点

  • FETO显著降低先天性膈疝胎儿1个月死亡率(OR 0.56)和6个月死亡率(OR 0.34)。
  • 重度膈疝中FETO显著降低肺动脉高压率和ECMO使用率,中度膈疝中无显著效果。
  • FETO增加37周前胎膜早破(OR 4.94)和37周前早产(OR 5.24)风险,但不增加32周前早产等严重并发症。

核心结论

  • FETO与重度先天性膈疝的死亡率、肺动脉高压率和ECMO使用率降低相关,而在中度先天性膈疝中仅降低死亡率。
  • FETO虽增加晚期早产风险,但不导致极早产。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE、Cochrane Library、中国知网、中国科技期刊数据库和万方数据库截至2022年9月8日发表的文献,无语种或研究设计限制。
  • 纳入标准为先天性膈疝胎儿接受FETO手术并与期待管理队列比较、至少报告一项结局的研究;定量合成共纳入20项研究1187例先天性膈疝胎儿。
  • 主要结局为出生后1、6、12个月死亡率、肺动脉高压率、体外膜肺氧合(ECMO)使用率和早产率;同时评估纳入研究和合并证据的质量。

主要发现

  • FETO显著降低1个月死亡率(OR 0.56(95%CI 0.34-0.93);P=0.02,需治疗人数(NNT)=7.67)和6个月死亡率(OR 0.34(95%CI 0.18-0.65);P=0.0009,NNT=5.26),证据质量中/低。
  • 亚组分析提示FETO对肺动脉高压率和ECMO使用率的影响在重度先天性膈疝中显著(证据质量低/中),在中度先天性膈疝中不显著(证据质量低/极低)。
  • FETO与37周前未足月胎膜早破风险增加相关(OR 4.94(95%CI 2.25-10.88);P<0.0001,需伤害人数(NNH)=3.13)和37周前早产风险增加相关(OR 5.24(95%CI 3.33-8.23);P<0.00001,NNH=2.79),证据质量高/中。
  • FETO与32周前早产、胎盘早剥或绒毛膜羊膜炎等严重并发症无显著关联(证据质量极低/低)。

局限性

  • 纳入研究的证据质量从极低到高不等,其中死亡率结局的证据质量为中/低,肺动脉高压和ECMO使用率在重度膈疝中的证据质量为低/中、在中度膈疝中为低/极低,严重并发症的证据质量为极低/低。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: It is debated whether fetal endoscopic tracheal occlusion (FETO) is beneficial to fetuses with congenital diaphragmatic hernia (CDH) and whether FETO has different effects in moderate and severe CDH. We conducted a systematic review and meta-analysis including the latest evidence to assess the overall effects of FETO on clinical outcomes of CDH. METHODS: We searched PubMed, EMBASE, The Cochrane Library, China National Knowledge Infrastructure, China Science and Technology Journal Database and Wanfang Database to retrieve eligible studies published before 8 September 2022. No language or study design restrictions were applied. Studies were included if CDH fetuses underwent FETO surgery and were compared with a cohort that underwent expectant management, with at least one outcome reported. The primary outcomes were mortality at 1, 6 and 12 months after birth, rates of pulmonary hypertension, use of extracorporeal membrane oxygenation (ECMO) and prematurity. Meta-analysis was conducted to obtain pooled odds ratios (ORs) and mean differences. The quality of included studies and pooled evidence was also assessed. RESULTS: A total of 1187 CDH fetuses from 20 studies were included in the quantitative synthesis. FETO significantly reduced 1-month (OR, 0.56 (95% CI, 0.34-0.93); P = 0.02, number needed to treat (NNT) = 7.67) and 6-month (OR, 0.34 (95% CI, 0.18-0.65); P = 0.0009, NNT = 5.26) CDH mortality (moderate/low quality of evidence). Subgroup analysis suggested that the effects of FETO on the rates of pulmonary hypertension and ECMO usage were significant in severe CDH (low/moderate quality of evidence) but not in moderate CDH (low/very low quality of evidence). FETO was also associated with an increased risk of preterm prelabor rupture of membranes before 37 weeks' gestation (OR, 4.94 (95% CI, 2.25-10.88); P < 0.0001, number needed to harm (NNH) = 3.13) and preterm birth before 37 weeks (OR, 5.24 (95% CI, 3.33-8.23); P < 0.00001, NNH = 2.79) (high/moderate quality of evidence). However, FETO was not associated with severe complications, such as preterm birth before 32 weeks, placental abruption or chorioamnionitis (very low/low quality of evidence). CONCLUSIONS: FETO is associated with a reduction in mortality, rate of pulmonary hypertension and ECMO usage in severe CDH, while it reduces only the risk of mortality in moderate CDH. Although FETO increases the risk of late prematurity, it does not result in extreme prematurity. © 2023 International Society of Ultrasound in Obstetrics and Gynecology.

来源:Ultrasound Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Chen Y, Xu R, Xie X, et al. Fetal endoscopic tracheal occlusion for congenital diaphragmatic hernia: systematic review and meta-analysis. Ultrasound Obstet Gynecol. 2023. PMID: 36704940. doi:10.1002/uog.26164

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。